Key statistics · As on 14 Oct 2026
Market cap
BDT 6,670.547 mn
Free float market cap
BDT 2,048.265 mn
NAV per share
BDT 45.29
P/E (audited)
13.79x
Day's value
BDT 10.21 mn
Day's volume
163,335
Day's trades
535
Opening price
BDT 62.20
Adjusted Opening Price
BDT 62.10
Yesterday's closing price
BDT 62.10
Closing price
BDT 62.60
Last Update
2:09 PM
Day's range
Current BDT 62.60
BDT 62.00BDT 62.90
52-week range
Current BDT 62.60
BDT 45.50BDT 78.00
Basics
- Listing year
- 2022
- Authorized Capital (mn)
- BDT 2,000
- Paid-up capital
- BDT 1,074.16 mn
- Face value
- BDT 10.00
- Total outstanding securities
- 107,416,217
- Market Lot
- 1
Shareholding pattern
as on Jun 28, 2025 (year ended)
as on Aug 31, 2026
as on Sep 30, 2026
Sponsor / Director
31.64%
31.64%
31.64%
Government
0.00%
0.00%
0.00%
Institution
9.42%
10.60%
11.11%
Foreign
19.63%
19.63%
19.63%
Public
39.31%
38.13%
37.62%
Shareholding percentages as reported by the listed company.
Sponsor/Director holdings reflect regulation 2(1)(r) of the DSE (Listing) Regulations 2015.
Corporate & contact
- Present Operational Status
- Active
- Head Office / Registered Office
- 99 Gulshan Avenue, Rupayan Golden Age, 6th Floor, Plot-6, Block-CWN(C), Dhaka-1212
- Factory Address
- 1071, 1073, North Rupshi, Tarabo Municipality, Rupganj, Narayanganj.
- Contact Phone
- 880-2-55033580-3
- Fax
- 880-2-55033579
- cs@navanapharma.com
- Company Secretary Name
- Lorens Shamol Mollick FCS
- Company Secretary Cell No.
- 01321 131222
- Company Secretary Telephone No.
- 02-55033580-3
- Company Secretary E-mail
- secretary@navanapharma.com
- Website
- www.navanapharma.com
- Loan status
- Short-term: BDT 51.82 mn · Long-term: BDT 11.02 mn
- Present Loan Status — as on
- —
- Credit rating
- Short-term: — · Long-term: —
- Last AGM
- 31-12-2025
- Year-end
- June
Details of Financial Statementhttps://navanapharma.com/page/audited-accounts
Price Sensitive Informationhttps://navanapharma.com/page/psi